Condition
Von Willebrand Disease (VWD) clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Von Willebrand Disease (VWD) clinical trials that are recruiting, at sites in 16 countries (most in United Kingdom (5), United States (5), Australia (3)). By phase: Phase 3 (3), Phase 2 (2), Phase 1/2 (1). The most active sponsors are Takeda (3), Hemab ApS (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 16Countries
Newest Von Willebrand Disease (VWD) clinical trials
All recruiting trials (10)
-
SR604 in Von Willebrand Disease: a Phase II study to see if it helps with bleeding
This Phase 2 trial tests SR604 in adults with von Willebrand disease to see if it can improve bleeding control and how the drug behaves in the body.
-
ALN-6400 for women with von Willebrand disease and heavy menstrual bleeding
This study tests ALN-6400 to see if it can help reduce heavy menstrual bleeding in adult and adolescent women with von Willebrand disease.
-
Vonicog alfa (rVWF) use in children with von Willebrand disease
This observational program will see how vonicog alfa (rVWF) works and whether it causes side effects in children with von Willebrand disease in Japan.
-
Endothelial colony-forming cell behavior in people with von Willebrand disease and acquired von Willebrand syndrome
This project will see how endothelial colony-forming cells (ECFCs) behave in people with VWD or AVWS compared with healthy volunteers.
-
VONVENDI treatment for adults in China with von Willebrand disease
We will test whether VONVENDI is safe and helps control bleeding in adult Chinese patients with severe von Willebrand disease, sometimes given with ADVATE if their factor VIII is low.
-
Subcutaneous VGA039 to prevent bleeds in people with von Willebrand disease
This study will test whether subcutaneous VGA039 can reduce bleeding in people aged 12–75 with any type of von Willebrand disease who have frequent bleeds.
-
Assessing HMB-002 for treating Von Willebrand Disease
This study is testing a new treatment called HMB-002 to see if it is safe and effective for adults with Type 1 Von Willebrand Disease.
-
Algorithm-based management to reduce GI bleeding and epistaxis in von Willebrand disease
This study tests whether an algorithm-guided, multidisciplinary management approach can cut back GI bleeding and severe nosebleeds in adults with von Willebrand disease compared with standard care.
-
Understanding bleeding and treatment in Von Willebrand Disease
This study is trying to learn more about bleeding and treatment experiences in people with Von Willebrand Disease, especially those with Type 1, to help improve future care.
-
Evaluating vonicog alfa for children with severe Von Willebrand Disease
This study is testing a new treatment called vonicog alfa to see if it can help children with severe Von Willebrand Disease manage their bleeding better.
Related topics
Quick answers
How many Von Willebrand Disease (VWD) clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United Kingdom (5 trials), United States (5 trials), Australia (3 trials), Italy (3 trials), Ireland (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.